Skip to main content
. 2017 Jun 6;7:2911. doi: 10.1038/s41598-017-02913-8

Figure 2.

Figure 2

Adjusted survival curves for any β-blocker use in the four month interval prior diagnosis for (A) all histologies, (B) non-small cell lung cancer (NSCLC) and (C) small cell lung cancer (SCLC).